Clinical Trial Update: Evolocumab Plus Ezetimibe in High Risk Haemodialized Statin Intolerant Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating evolocumab plus ezetimibe in high-risk statin-intolerant patients undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Chronic Kidney Disease Requiring Chronic Dialysis
• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Evolocumab (evolocumab)

Snippet

Sponsor: Policlinico Casilino ASL RMB | Conditions: Hypercholesterolemia, Chronic Kidney Disease Requiring Chronic Dialysis | Phase 4 | Status: UNKNOWN